Li-Tzong Chen Selected Research

Phosphoric Monoester Hydrolases (Phosphatases)

11/2022	PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
4/2019	Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
12/2017	Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.
11/2017	The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Tzong Chen Research Topics

Disease

101	Neoplasms (Cancer) 02/2024 - 09/2002
40	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 03/2006
31	Adenocarcinoma 03/2024 - 11/2013
17	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2003
16	Stomach Neoplasms (Stomach Cancer) 02/2024 - 01/2002
14	Disease Progression 01/2023 - 09/2005
14	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2022 - 12/2006
14	Lymphoma (Lymphomas) 01/2020 - 06/2003
13	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2022 - 08/2004
11	Carcinogenesis 02/2023 - 02/2012
11	Neoplasm Metastasis (Metastasis) 12/2022 - 12/2013
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 07/2015
7	Carcinoma (Carcinomatosis) 04/2019 - 07/2004
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 09/2005
6	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019 - 10/2008
5	Neutropenia 10/2021 - 01/2002
5	Infections 01/2021 - 09/2005
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2004
5	Nasopharyngeal Carcinoma 03/2014 - 07/2002
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 07/2009
4	Primitive Neuroectodermal Tumors (PNET) 11/2022 - 11/2017
4	Hemorrhage 09/2022 - 11/2005
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 12/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 10/2016
3	Melanoma (Melanoma, Malignant) 01/2023 - 10/2015
3	Fatigue 01/2023 - 02/2016
3	Cholangiocarcinoma 01/2023 - 01/2018
3	Febrile Neutropenia 01/2022 - 01/2002
3	Adenocarcinoma of Lung 01/2022 - 06/2015
3	Thrombocytopenia (Thrombopenia) 10/2021 - 05/2006
3	Fever (Fevers) 01/2020 - 05/2006
3	Necrosis 02/2017 - 07/2004
3	Hepatitis B 01/2016 - 06/2010
2	Squamous Cell Carcinoma of Head and Neck 11/2023 - 01/2023
2	Liver Diseases (Liver Disease) 09/2022 - 09/2005
2	Liver Neoplasms (Liver Cancer) 05/2022 - 07/2014
2	Splenomegaly 01/2022 - 09/2005
2	Sepsis (Septicemia) 01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

35	Gemcitabine FDA Link 03/2024 - 03/2006
34	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2002
33	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2002
23	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 02/2016
16	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2012
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2004
12	Imatinib Mesylate (Gleevec)FDA Link 12/2022 - 12/2006
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2012
10	NivolumabIBA 10/2022 - 12/2017
10	Thalidomide (Thalomid)FDA Link 02/2022 - 01/2003
8	Phosphotransferases (Kinase)IBA 04/2021 - 01/2008
8	Everolimus FDA Link 11/2017 - 05/2011
7	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 01/2002
6	Tyrosine Kinase InhibitorsIBA 12/2022 - 01/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 09/2005
6	EnzymesIBA 01/2022 - 09/2016
6	Messenger RNA (mRNA)IBA 08/2017 - 04/2012
5	CateninsIBA 02/2022 - 01/2019
5	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2011
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2012
4	AntigensIBA 01/2023 - 10/2013
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022 - 11/2017
4	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 12/2013
4	Antineoplastic Agents (Antineoplastics)IBA 02/2022 - 07/2002
4	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2021 - 10/2014
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 01/2008
4	7-hydroxy-6-methoxyphthalide (MA-1)IBA 02/2017 - 11/2011
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2024 - 11/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2021
3	ChromatinIBA 01/2022 - 08/2012
3	RamucirumabIBA 10/2021 - 10/2017
3	ADI PEG20IBA 01/2021 - 06/2013
3	Cetuximab (Erbitux)FDA Link 06/2019 - 09/2014
3	Arginine (L-Arginine)FDA Link 12/2017 - 06/2013
3	MTOR InhibitorsIBA 11/2017 - 05/2011
3	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 11/2003
3	PlatinumIBA 01/2016 - 07/2009
3	Indicators and Reagents (Reagents)IBA 02/2014 - 04/2012
3	NF-kappa B (NF-kB)IBA 10/2008 - 09/2004
3	ParaffinIBA 01/2008 - 09/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2022
2	Peptides (Polypeptides)IBA 01/2024 - 04/2004
2	durvalumabIBA 11/2023 - 08/2022
2	regorafenibIBA 02/2023 - 07/2017
2	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2017
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023 - 01/2018
2	TensinsIBA 11/2022 - 11/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2022 - 03/2014
2	Semaphorins (Semaphorin)IBA 02/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2015
2	AlbuminsIBA 01/2022 - 09/2005

Therapy/Procedure

62	Therapeutics 02/2024 - 01/2004
35	Drug Therapy (Chemotherapy) 11/2023 - 06/2003
7	Radiotherapy 01/2023 - 01/2004
6	Chemoradiotherapy 11/2023 - 12/2011
4	Neoadjuvant Therapy 09/2023 - 08/2012
3	Immunotherapy 11/2023 - 11/2018
3	Adjuvant Chemotherapy 09/2023 - 01/2022
3	Salvage Therapy 01/2022 - 12/2011
3	Induction Chemotherapy 01/2022 - 12/2011
2	Gastrectomy 01/2023 - 11/2021